Absence of Biallelic TCRγ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia Chemotherapy-naive patients with GI tract cancers scheduled for ...

ORLANDO—Patients with metastatic renal cell carcincoma (RCC) who develop hand-foot syndrome (HFS) while being treated with sunitinib may have better progression-free survival and overall survival than ...

Onquality Pharmaceuticals LLC has received FDA clearance of its IND application for OQL-036, a potential prophylactic treatment for capecitabine-induced hand-foot syndrome (HFS).

Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...

Chemotherapy-induced hand-foot syndrome (HFS) is a common and distressing side effect experienced by patients undergoing cancer treatment. This condition, also known as palmar-plantar ...

Michael Allio made a promise to his late wife, Laura. He vowed to continue an initiative they started together — to help people reduce their pain from a common side effect of chemotherapy called ...